180 related articles for article (PubMed ID: 37149693)
21. CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.
Sarrou E; Richmond L; Carmody RJ; Gibson B; Keeshan K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549410
[TBL] [Abstract][Full Text] [Related]
22. Increased circulating colony-stimulating factor-1 (CSF-1) in SJL/J mice with radiation-induced acute myeloid leukemia (AML) is associated with autocrine regulation of AML cells by CSF-1.
Haran-Ghera N; Krautghamer R; Lapidot T; Peled A; Dominguez MG; Stanley ER
Blood; 1997 Apr; 89(7):2537-45. PubMed ID: 9116300
[TBL] [Abstract][Full Text] [Related]
23. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia.
Chu Y; Chen Y; Li M; Shi D; Wang B; Lian Y; Cheng X; Wang X; Xu M; Cheng T; Shi J; Yuan W
Cancer Sci; 2019 Jul; 110(7):2200-2210. PubMed ID: 31050834
[TBL] [Abstract][Full Text] [Related]
24. Organ-specific microenvironment modifies diverse functional and phenotypic characteristics of leukemia-associated macrophages in mouse T cell acute lymphoblastic leukemia.
Chen SY; Yang X; Feng WL; Liao JF; Wang LN; Feng L; Lin YM; Ren Q; Zheng GG
J Immunol; 2015 Mar; 194(6):2919-29. PubMed ID: 25662994
[TBL] [Abstract][Full Text] [Related]
25. Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes.
Budel LM; Elbaz O; Hoogerbrugge H; Delwel R; Mahmoud LA; Löwenberg B; Touw IP
Blood; 1990 Apr; 75(7):1439-45. PubMed ID: 2156580
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
Blondy T; d'Almeida SM; Briolay T; Tabiasco J; Meiller C; Chéné AL; Cellerin L; Deshayes S; Delneste Y; Fonteneau JF; Boisgerault N; Bennouna J; Grégoire M; Jean D; Blanquart C
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581053
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
Arnoletti JP; Reza J; Rosales A; Monreal A; Fanaian N; Whisner S; Srivastava M; Rivera-Otero J; Yu G; Phanstiel Iv O; Altomare DA; Tran Q; Litherland SA
PLoS One; 2022; 17(3):e0265725. PubMed ID: 35316296
[TBL] [Abstract][Full Text] [Related]
28. WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.
Zhou B; Jin X; Jin W; Huang X; Wu Y; Li H; Zhu W; Qin X; Ye H; Gao S
J Transl Med; 2020 Jun; 18(1):254. PubMed ID: 32580769
[TBL] [Abstract][Full Text] [Related]
29. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
30. Sox13 functionally complements the related Sox5 and Sox6 as important developmental modulators in mouse spinal cord oligodendrocytes.
Baroti T; Schillinger A; Wegner M; Stolt CC
J Neurochem; 2016 Jan; 136(2):316-28. PubMed ID: 26525805
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia.
Cozzolino F; Torcia M; Bettoni S; Aldinucci D; Burgio VL; Petti MC; Rubartelli A; Barbui T; Rambaldi A
Int J Cancer; 1990 Nov; 46(5):902-7. PubMed ID: 1699903
[TBL] [Abstract][Full Text] [Related]
32. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors.
Estrov Z; Kurzrock R; Estey E; Wetzler M; Ferrajoli A; Harris D; Blake M; Gutterman JU; Talpaz M
Blood; 1992 Apr; 79(8):1938-45. PubMed ID: 1373331
[TBL] [Abstract][Full Text] [Related]
34. CSF-1R inhibition disrupts the dialog between leukaemia cells and macrophages and delays leukaemia progression.
Li K; Xu W; Lu K; Wen Y; Xin T; Shen Y; Lv X; Hu S; Jin R; Wu X
J Cell Mol Med; 2020 Nov; 24(22):13115-13128. PubMed ID: 33037771
[TBL] [Abstract][Full Text] [Related]
35. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
[TBL] [Abstract][Full Text] [Related]
36. Interleukins and colony stimulating factors in human myeloid leukemia cell lines.
Hassan HT; Drexler HG
Leuk Lymphoma; 1995 Dec; 20(1-2):1-15. PubMed ID: 8750618
[TBL] [Abstract][Full Text] [Related]
37. Establishment and characterization of a new granulocyte-macrophage colony-stimulating factor-dependent and interleukin-3-dependent human acute myeloid leukemia cell line (GF-D8).
Rambaldi A; Bettoni S; Tosi S; Giudici G; Schirò R; Borleri GM; Abbate M; Chiaffarino F; Colotta F; Barbui T
Blood; 1993 Mar; 81(5):1376-83. PubMed ID: 8443395
[TBL] [Abstract][Full Text] [Related]
38. Sex-determining Region Y-box transcription factor 13 promotes breast cancer cell proliferation and glycolysis by activating the tripartite motif containing 11-mediated Wnt/β-catenin signaling pathway.
Jin X; Shao X; Pang W; Wang Z; Huang J
Bioengineered; 2022 May; 13(5):13033-13044. PubMed ID: 35611828
[TBL] [Abstract][Full Text] [Related]
39. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.
Oster W; Cicco NA; Klein H; Hirano T; Kishimoto T; Lindemann A; Mertelsmann RH; Herrmann F
J Clin Invest; 1989 Aug; 84(2):451-7. PubMed ID: 2788173
[TBL] [Abstract][Full Text] [Related]
40. TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice.
Xie X; Zhang W; Xiao M; Wei T; Qiu Y; Qiu J; Wang H; Qiu Z; Zhang S; Pan Y; Mao L; Li Y; Guo B; Yang W; Hu Y; Hu S; Gong Y; Yang J; Xiao G; Zhang Y; Bai X
Blood; 2023 Jun; 141(26):3184-3198. PubMed ID: 37001042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
